Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Urol. 2011 Nov;186(5):1779-85. doi: 10.1016/j.juro.2011.07.041. Epub 2011 Sep 25.
Despite benefits in functional renal outcome and the similar oncological efficacy of partial nephrectomy for renal cell carcinoma, previous studies show marked underuse of partial nephrectomy. We describe national trends in partial and radical nephrectomy using a contemporary, population based cohort.
Using the 2003 to 2008 Nationwide Inpatient Sample we identified 188,702 patients treated with partial or radical nephrectomy for renal cell carcinoma at a total of 1,755 hospitals. Multivariate logistic regression was used to assess the independent associations of patient and hospital characteristics with partial nephrectomy. Post-estimations from multivariate logistic regression were done to ascertain the annual predicted probability of partial nephrectomy by hospital feature.
Overall 149,636 (79.3%) and 39,066 patients (20.7%) underwent radical and partial nephrectomy for renal cell carcinoma, respectively. Partial nephrectomy use increased each year from 16.8% in 2003 to 25.1% in 2008 (p for trend <0.001). On multivariate analysis patients were more likely to undergo partial nephrectomy at teaching (OR 1.31, p <0.001) and urban (OR 1.13, p = 0.05) hospitals compared to nonteaching and rural hospitals, respectively. Each quartile of higher nephrectomy annual volume was associated with higher odds of partial nephrectomy compared to the lowest quartile (OR 1.21, p <0.001). Although annual predicted partial nephrectomy use increased across all hospitals, differences in annual partial nephrectomy use by teaching status, site (urban vs rural) and case volume persisted with time.
Although the use of partial nephrectomy for renal cell carcinoma is increasing nationally across all hospitals, academic and urban hospitals as well as those with higher nephrectomy volume continue to show higher partial nephrectomy use for renal cell carcinoma.
尽管部分肾切除术在肾功能结果和肿瘤学疗效方面具有优势,但先前的研究表明,部分肾切除术的应用明显不足。我们描述了使用当代人群队列进行部分和根治性肾切除术的全国趋势。
我们使用 2003 年至 2008 年全国住院患者样本,在总共 1755 家医院中确定了 188702 例接受部分或根治性肾切除术治疗肾细胞癌的患者。多变量逻辑回归用于评估患者和医院特征与部分肾切除术的独立关联。通过多元逻辑回归的后估计,确定了按医院特征预测的每年部分肾切除术的概率。
总体而言,149636 例(79.3%)和 39066 例(20.7%)患者分别接受根治性和部分肾切除术治疗肾细胞癌。部分肾切除术的使用率逐年增加,从 2003 年的 16.8%增加到 2008 年的 25.1%(趋势 p <0.001)。多元分析显示,与非教学和农村医院相比,患者在教学(OR 1.31,p <0.001)和城市(OR 1.13,p = 0.05)医院接受部分肾切除术的可能性更高。与最低四分位相比,每个四分位较高的肾切除术年手术量与部分肾切除术的可能性更高相关(OR 1.21,p <0.001)。尽管所有医院的部分肾切除术使用率都在增加,但教学状态、地点(城市与农村)和病例量的年度部分肾切除术使用率差异仍随时间持续存在。
尽管全国所有医院的肾细胞癌部分肾切除术的使用率都在增加,但学术和城市医院以及肾切除术量较高的医院继续显示出更高的肾细胞癌部分肾切除术使用率。